Loading…
Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells
Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and...
Saved in:
Published in: | Neural regeneration research 2020-12, Vol.15 (12), p.2296-2305 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 2305 |
container_issue | 12 |
container_start_page | 2296 |
container_title | Neural regeneration research |
container_volume | 15 |
creator | Tao, Wen-Yuan Yu, Lin-Jie Jiang, Su Cao, Xiang Chen, Jian Bao, Xin-Yu Li, Fei Xu, Yun Zhu, Xiao-Lei |
description | Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways. |
doi_str_mv | 10.4103/1673-5374.285006 |
format | article |
fullrecord | <record><control><sourceid>wanfang_jour_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4c202693cf1541ea9f1cad71639ed9cf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>zgsjzsyj_e202012026</wanfj_id><doaj_id>oai_doaj_org_article_4c202693cf1541ea9f1cad71639ed9cf</doaj_id><sourcerecordid>zgsjzsyj_e202012026</sourcerecordid><originalsourceid>FETCH-LOGICAL-d475o-4a7dfee084a467fda82b962509f266377f00eb0a51a43b3c39890c4f0fdc46513</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhi0EoqVw5xiJI0oZf8cXpLLio9KqXNoLF8vrjJekabzYSVftz-KH8JvwstuinmY0H8-8mpeQtxROBQX-gSrNa8m1OGWNBFDPyDFttKq1kc3zkj-0j8irnHsA2RjGX5IjzqQRINkx-XSBc4qbFCf0U3eLFYZQslzFUP1YFmTVjdXZn9-0FqyeEroJ22rc7YxuqDwOQ35NXgQ3ZHxziCfk6svny8W3evn96_nibFm3QstYC6fbgAiNcELp0LqGrYxiEkxgSnGtAwCuwEnqBF9xz01jwIsAofVCScpPyPme20bX203qbly6s9F19l8hprV1aer8gFZ4BkwZ7gOVgqIzgXrXaqq4wdb4UFgf96zNvLrB1uM4JTc8gT7tjN1Pu463VmthhIICeL8HbN0Y3Li2fZxTeUm29-vc3-e73mLRAHQnpEy_O5xL8deMefo_zgTVRoExO-biwIzDhClfD_MWky0qrse4tRTsznT76Krdm24ZM8o--Mj_Am6hobA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417960990</pqid></control><display><type>article</type><title>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Tao, Wen-Yuan ; Yu, Lin-Jie ; Jiang, Su ; Cao, Xiang ; Chen, Jian ; Bao, Xin-Yu ; Li, Fei ; Xu, Yun ; Zhu, Xiao-Lei</creator><creatorcontrib>Tao, Wen-Yuan ; Yu, Lin-Jie ; Jiang, Su ; Cao, Xiang ; Chen, Jian ; Bao, Xin-Yu ; Li, Fei ; Xu, Yun ; Zhu, Xiao-Lei</creatorcontrib><description>Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.</description><identifier>ISSN: 1673-5374</identifier><identifier>EISSN: 1876-7958</identifier><identifier>DOI: 10.4103/1673-5374.285006</identifier><identifier>PMID: 32594052</identifier><language>eng</language><publisher>Mumbai: Wolters Kluwer India Pvt. Ltd</publisher><subject>akt; alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; nrf2; oxidative stress; treatment; zl006 ; Apoptosis ; Membranes ; Neuroblastoma ; Oxidative stress ; Polyclonal antibodies ; Proteins</subject><ispartof>Neural regeneration research, 2020-12, Vol.15 (12), p.2296-2305</ispartof><rights>2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>Copyright: © 2020 Neural Regeneration Research 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/zgsjzsyj-e/zgsjzsyj-e.jpg</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2417960990/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2417960990?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768,74869</link.rule.ids></links><search><creatorcontrib>Tao, Wen-Yuan</creatorcontrib><creatorcontrib>Yu, Lin-Jie</creatorcontrib><creatorcontrib>Jiang, Su</creatorcontrib><creatorcontrib>Cao, Xiang</creatorcontrib><creatorcontrib>Chen, Jian</creatorcontrib><creatorcontrib>Bao, Xin-Yu</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Xu, Yun</creatorcontrib><creatorcontrib>Zhu, Xiao-Lei</creatorcontrib><title>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</title><title>Neural regeneration research</title><description>Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.</description><subject>akt; alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; nrf2; oxidative stress; treatment; zl006</subject><subject>Apoptosis</subject><subject>Membranes</subject><subject>Neuroblastoma</subject><subject>Oxidative stress</subject><subject>Polyclonal antibodies</subject><subject>Proteins</subject><issn>1673-5374</issn><issn>1876-7958</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpVkU1v1DAQhi0EoqVw5xiJI0oZf8cXpLLio9KqXNoLF8vrjJekabzYSVftz-KH8JvwstuinmY0H8-8mpeQtxROBQX-gSrNa8m1OGWNBFDPyDFttKq1kc3zkj-0j8irnHsA2RjGX5IjzqQRINkx-XSBc4qbFCf0U3eLFYZQslzFUP1YFmTVjdXZn9-0FqyeEroJ22rc7YxuqDwOQ35NXgQ3ZHxziCfk6svny8W3evn96_nibFm3QstYC6fbgAiNcELp0LqGrYxiEkxgSnGtAwCuwEnqBF9xz01jwIsAofVCScpPyPme20bX203qbly6s9F19l8hprV1aer8gFZ4BkwZ7gOVgqIzgXrXaqq4wdb4UFgf96zNvLrB1uM4JTc8gT7tjN1Pu463VmthhIICeL8HbN0Y3Li2fZxTeUm29-vc3-e73mLRAHQnpEy_O5xL8deMefo_zgTVRoExO-biwIzDhClfD_MWky0qrse4tRTsznT76Krdm24ZM8o--Mj_Am6hobA</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Tao, Wen-Yuan</creator><creator>Yu, Lin-Jie</creator><creator>Jiang, Su</creator><creator>Cao, Xiang</creator><creator>Chen, Jian</creator><creator>Bao, Xin-Yu</creator><creator>Li, Fei</creator><creator>Xu, Yun</creator><creator>Zhu, Xiao-Lei</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><general>The State Key Laboratory of Pharmaceutical Biotechnology,Nanjing University,Nanjing,Jiangsu Province,China</general><general>Department of Neurology,Drum Tower Hospital,Medical School of Nanjing University,Nanjing,Jiangsu Province,China</general><general>Jiangsu Key Laboratory for Molecular Medicine,Nanjing,Jiangsu Province,China 4 Taizhou People's Hospital,Taizhou,Jiangsu Province,China%Department of Medicinal Chemistry,School of Pharmacy,Nanjing Medical University,Nanjing,Jiangsu Province,China</general><general>Wolters Kluwer - Medknow</general><general>Wolters Kluwer Medknow Publications</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20201201</creationdate><title>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</title><author>Tao, Wen-Yuan ; Yu, Lin-Jie ; Jiang, Su ; Cao, Xiang ; Chen, Jian ; Bao, Xin-Yu ; Li, Fei ; Xu, Yun ; Zhu, Xiao-Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d475o-4a7dfee084a467fda82b962509f266377f00eb0a51a43b3c39890c4f0fdc46513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>akt; alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; nrf2; oxidative stress; treatment; zl006</topic><topic>Apoptosis</topic><topic>Membranes</topic><topic>Neuroblastoma</topic><topic>Oxidative stress</topic><topic>Polyclonal antibodies</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tao, Wen-Yuan</creatorcontrib><creatorcontrib>Yu, Lin-Jie</creatorcontrib><creatorcontrib>Jiang, Su</creatorcontrib><creatorcontrib>Cao, Xiang</creatorcontrib><creatorcontrib>Chen, Jian</creatorcontrib><creatorcontrib>Bao, Xin-Yu</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Xu, Yun</creatorcontrib><creatorcontrib>Zhu, Xiao-Lei</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neural regeneration research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tao, Wen-Yuan</au><au>Yu, Lin-Jie</au><au>Jiang, Su</au><au>Cao, Xiang</au><au>Chen, Jian</au><au>Bao, Xin-Yu</au><au>Li, Fei</au><au>Xu, Yun</au><au>Zhu, Xiao-Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</atitle><jtitle>Neural regeneration research</jtitle><date>2020-12-01</date><risdate>2020</risdate><volume>15</volume><issue>12</issue><spage>2296</spage><epage>2305</epage><pages>2296-2305</pages><issn>1673-5374</issn><eissn>1876-7958</eissn><abstract>Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.</abstract><cop>Mumbai</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>32594052</pmid><doi>10.4103/1673-5374.285006</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1673-5374 |
ispartof | Neural regeneration research, 2020-12, Vol.15 (12), p.2296-2305 |
issn | 1673-5374 1876-7958 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_4c202693cf1541ea9f1cad71639ed9cf |
source | Publicly Available Content Database; PubMed Central |
subjects | akt alzheimer’s disease amyloid-beta apoptosis heme oxygenase-1 neurotoxicity nrf2 oxidative stress treatment zl006 Apoptosis Membranes Neuroblastoma Oxidative stress Polyclonal antibodies Proteins |
title | Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T10%3A00%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20effects%20of%20ZL006%20in%20A%CE%B21-42-treated%20neuronal%20cells&rft.jtitle=Neural%20regeneration%20research&rft.au=Tao,%20Wen-Yuan&rft.date=2020-12-01&rft.volume=15&rft.issue=12&rft.spage=2296&rft.epage=2305&rft.pages=2296-2305&rft.issn=1673-5374&rft.eissn=1876-7958&rft_id=info:doi/10.4103/1673-5374.285006&rft_dat=%3Cwanfang_jour_doaj_%3Ezgsjzsyj_e202012026%3C/wanfang_jour_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d475o-4a7dfee084a467fda82b962509f266377f00eb0a51a43b3c39890c4f0fdc46513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2417960990&rft_id=info:pmid/32594052&rft_wanfj_id=zgsjzsyj_e202012026&rfr_iscdi=true |